Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-19 7:09 pm Purchase | 13G | ABIVAX SA SPONSORED ADS ABVX | TCG Crossover GP I LLC | 6,056,596 9.600% | 6,056,596 (New Position) | View |
| 2024-04-01 4:14 pm Sale | 13D | KALVISTA PHARMACEUTICALS INC C KALV | TCG Crossover GP I LLC | 1,345,826 3.200% | -1,355,014 (-50.17%) | View |
| 2024-02-20 4:49 pm Sale | 13D | KALVISTA PHARMACEUTICALS INC C KALV | TCG Crossover GP I LLC | 2,700,840 6.520% | -707,241 (-20.75%) | View |
| 2024-02-13 4:27 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | TCG Crossover GP I LLC | 0 0.000% | -5,905,400 (Position Closed) | View |
| 2024-02-09 4:31 pm Purchase | 13G | CG Oncology Inc. CGON | TCG Crossover GP I LLC | 3,570,206 5.400% | 3,570,206 (New Position) | View |
| 2024-02-09 4:29 pm Purchase | 13G | AN2 THERAPEUTICS INC ANTX | TCG Crossover GP I LLC | 2,678,209 9.000% | 1,388,889 (+107.72%) | View |
| 2024-02-09 4:28 pm Purchase | 13G | AEROVATE THERAPEUTICS INC AVTE | TCG Crossover GP I LLC | 2,201,274 8.000% | 2,201,274 (New Position) | View |
| 2024-02-09 4:24 pm Sale | 13G | TAYSHA GENE THERAPIES INC TSHA | TCG Crossover GP I LLC | 2,912,861 1.600% | -8,198,250 (-73.78%) | View |
| 2024-02-09 4:22 pm Purchase | 13G | TOURMALINE BIO INC TRML | TCG Crossover GP I LLC | 1,477,593 5.900% | 1,477,593 (New Position) | View |
| 2024-02-09 4:22 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | TCG Crossover GP I LLC | 5,631,042 6.500% | 2,000,000 (+55.08%) | View |
| 2023-08-28 4:08 pm Purchase | 13G | COMPASS Pathways plc CMPS | TCG Crossover GP I LLC | 6,437,497 9.900% | 6,437,497 (New Position) | View |
| 2023-08-25 4:22 pm Purchase | 13G | TAYSHA GENE THERAPIES INC TSHA | TCG Crossover GP I LLC | 11,111,111 5.900% | 11,111,111 (New Position) | View |
| 2023-07-25 4:19 pm Purchase | 13G | AN2 THERAPEUTICS INC ANTX | TCG Crossover GP I LLC | 1,289,320 6.600% | 1,289,320 (New Position) | View |
| 2023-07-25 4:18 pm Purchase | 13G | Icosavax Inc. ICVX | TCG Crossover GP I LLC | 3,703,704 7.500% | 3,703,704 (New Position) | View |
| 2023-07-25 4:17 pm Purchase | 13G | Savara Inc SVRA | TCG Crossover GP I LLC | 10,000,000 7.400% | 10,000,000 (New Position) | View |
| 2023-02-14 2:23 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | TCG Crossover GP I LLC | 3,631,042 5.200% | 3,631,042 (New Position) | View |
| 2023-02-14 2:23 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | TCG Crossover GP I LLC | 5,905,400 6.200% | 5,905,400 (New Position) | View |
| 2023-02-14 2:23 pm Purchase | 13G | SILENCE THERAPEUTICS PLC SPONS SLN | TCG Crossover GP I LLC | 6,314,625 5.900% | 6,314,625 (New Position) | View |
| 2023-02-14 2:23 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | TCG Crossover GP I LLC | 983,610 2.400% | 983,610 (New Position) | View |
| 2023-01-09 4:19 pm Purchase | 13D | KALVISTA PHARMACEUTICALS INC C KALV | TCG Crossover GP I LLC | 3,408,081 9.900% | 3,408,081 (New Position) | View |